Our CKD Screening Prioritizer is a registered medical device.
Our Chronic Kidney Disease Screening Prioritizer (CSP) has
received a UKCA marking and regulatory approval meaning it is a registered medical device in the...
Gendius presents at American Society of Nephrology Conference
Diabetes technology innovator Gendius has presented research on its new data-driven tool to identify type-2 diabetes patients at higher risk of having reduced kidney function at the American...
Research shows Gendius’ models can identify high risk patients
Newly published research shows that Gendius’ models can identify which people with diabetes are at high risk of renal impairment
Research published in...
Gendius presents at European Association for the Study of Diabetes (EASD) conference
Gendius presents validation of Chronic Kidney Disease pre-screening models at European Association for the Study of Diabetes (EASD) conference
UK...
Gendius technology for diabetes risk prediction launched in the GCC
Gendius technology for diabetes risk prediction launched in the GCC through new AstraZeneca patient support app, Health Gate
A new digital health...
